Detalhe da pesquisa
1.
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
Ann Hematol
; 103(2): 437-442, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060001
2.
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis.
Am J Hematol
; 99(1): 68-78, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846894
3.
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis.
J Allergy Clin Immunol
; 151(2): 485-493.e11, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309122
4.
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis.
Am J Hematol
; 97(7): 846-855, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338671
5.
Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management.
Int J Mol Sci
; 23(15)2022 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955907
6.
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.
Am J Hematol
; 96(11): 1472-1480, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424575
7.
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis.
Am J Hematol
; 94(8): 845-852, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31056768
8.
Diagnostic and therapeutic challenges in mast cell sarcoma.
Am J Hematol
; 98(3): 529-532, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464921
9.
Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs*12 mutation.
Blood
; 133(26): 2802-2808, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076447
10.
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.
Am J Hematol
; 91(7): 692-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27060898
11.
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease.
Am J Hematol
; 95(12): 1622-1624, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242958
12.
One thousand patients with essential thrombocythemia: the Florence-CRIMM experience.
Blood Cancer J
; 14(1): 10, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238287
13.
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.
NEJM Evid
; 2(6): EVIDoa2200335, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320126
14.
Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms.
Am J Hematol
; 91(9): E356, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27237057
15.
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRß, FGFR1 or PCM1-JAK2.
Biomark Res
; 9(1): 83, 2021 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34772467
16.
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis.
Cancers (Basel)
; 13(19)2021 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638230
17.
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis.
Blood Adv
; 5(5): 1452-1462, 2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33666652
18.
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea.
Blood Cancer J
; 8(12): 122, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30467377
19.
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.
Leukemia
; 34(8): 2234-2237, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32047238
20.
Validation of the Mayo alliance prognostic system for mastocytosis.
Blood Cancer J
; 9(2): 18, 2019 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30741929